During the past decade, PrimeHealth Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PrimeHealth Clinical Research" #1 sponsor was "Bayer" with 2 trials, followed by "Cortria Corporation" with 1 trials sponsored, "Forest Laboratories" with 1 trials sponsored, "Johnson & Johnson Consumer Inc. (J&JCI)" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PrimeHealth Clinical Research" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Montreal Heart Institute" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "PrimeHealth Clinical Research" are "Arthritis, Rheumatoid" (1 trials), "Chronic Constipation" (1 trials), "Common Cold" (1 trials), "Contraception" (1 trials) and "Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "PrimeHealth Clinical Research" in a lesser frequency.

Most popular intervention types in "PrimeHealth Clinical Research" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027)" (1 trials), "Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)" (1 trials), "Ibuprofen" (1 trials) and "Linaclotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "PrimeHealth Clinical Research" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "PrimeHealth Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in PrimeHealth Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in PrimeHealth Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".